Deutsche Bank’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$19.9K Buy
+6,045
New +$20.1K ﹤0.01% 3553
2026
Q2
– Sell
-16,257
Closed -$31.9K – 3766
2026
Q1
$31.9K Hold
16,257
– – ﹤0.01% 3513
2025
Q4
$44.1K Hold
16,257
– – ﹤0.01% 3473
2025
Q3
$68.8K Hold
16,257
– – ﹤0.01% 3396
2025
Q2
$81K Sell
16,257
-13,123
-45% -$57K ﹤0.01% 3324
2025
Q1
$130K Hold
29,380
– – ﹤0.01% 3123
2024
Q4
$137K Buy
+29,380
New +$161K ﹤0.01% 3214
2021
Q4
– Sell
-40,006
Closed -$1.64M – 4303
2021
Q3
$1.64M Buy
40,006
+15,850
+66% +$575K ﹤0.01% 2258
2021
Q2
$870K Buy
+24,156
New +$891K ﹤0.01% 2861
2021
Q1
– Sell
-1,462
Closed -$59K – 4582
2020
Q4
$59K Buy
+1,462
New +$67.2K ﹤0.01% 4071

Other funds holding GDRX

Deutsche Bank's GDRX Position: Q3 2026 in Review

Deutsche Bank opened a new position in GoodRx Holdings (GDRX) in Q3 2026: 6,045 shares worth $19.9K. The stake represents ﹤0.01% of the portfolio and ranks #3553 among its holdings. This is a return to the name: Deutsche Bank previously reported a position in GDRX as recently as Q1 2026.

Deutsche Bank first reported a position in GDRX in Q4 2020 and has held it in 10 quarters since. The position peaked at $1.64M in Q3 2021. 182 funds tracked by Wall St. Rank hold GDRX as of Q3 2026.

  • Deutsche Bank held 6,045 shares of GoodRx Holdings worth $19.9K as of Q3 2026.
  • GoodRx Holdings was a new Deutsche Bank position in Q3 2026.
  • GoodRx Holdings made up ﹤0.01% of Deutsche Bank's portfolio in Q3 2026, its #3553 holding.
  • Deutsche Bank first reported a position in GoodRx Holdings in Q4 2020 and has held it in 10 quarters since.
  • Deutsche Bank's GoodRx Holdings position peaked at $1.64M in Q3 2021.
  • 182 funds tracked by Wall St. Rank held GoodRx Holdings as of Q3 2026.

Based on Deutsche Bank's 13F filing for Q3 2026, filed 6 Nov 2026.